88 related articles for article (PubMed ID: 19709958)
21. Quantitative analysis of 3-D conformal MRI-guided transurethral ultrasound therapy of the prostate: theoretical simulations.
Burtnyk M; Chopra R; Bronskill MJ
Int J Hyperthermia; 2009 Mar; 25(2):116-31. PubMed ID: 19337912
[TBL] [Abstract][Full Text] [Related]
22. Spatiotemporal filtering of MR-temperature artifacts arising from bowel motion during transurethral MR-HIFU.
Schmitt A; Mougenot C; Chopra R
Med Phys; 2014 Nov; 41(11):113302. PubMed ID: 25370670
[TBL] [Abstract][Full Text] [Related]
23. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
[TBL] [Abstract][Full Text] [Related]
24. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
[TBL] [Abstract][Full Text] [Related]
25. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive determination of tissue thermal parameters from high intensity focused ultrasound treatment monitored by volumetric MRI thermometry.
Dragonu I; de Oliveira PL; Laurent C; Mougenot C; Grenier N; Moonen CT; Quesson B
NMR Biomed; 2009 Oct; 22(8):843-51. PubMed ID: 19562728
[TBL] [Abstract][Full Text] [Related]
27. High intensity focused ultrasound ablation of kidney guided by MRI.
Damianou C; Pavlou M; Velev O; Kyriakou K; Trimikliniotis M
Ultrasound Med Biol; 2004 Mar; 30(3):397-404. PubMed ID: 15063522
[TBL] [Abstract][Full Text] [Related]
28. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
[TBL] [Abstract][Full Text] [Related]
29. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
Uchida T; Illing RO; Cathcart PJ; Emberton M
BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
[TBL] [Abstract][Full Text] [Related]
30. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
31. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
32. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
[TBL] [Abstract][Full Text] [Related]
33. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
34. Current status of HIFU and cryotherapy in prostate cancer--a review.
Aus G
Eur Urol; 2006 Nov; 50(5):927-34; discussion 934. PubMed ID: 16971038
[TBL] [Abstract][Full Text] [Related]
35. Experimental investigation of thermal effects in HIFU-based external valvuloplasty with a non-spherical transducer, using high-resolution MR thermometry.
Petrusca L; Salomir R; Milleret R; Pichot O; Rata M; Cotton F; Chapelon JY
Phys Med Biol; 2009 Sep; 54(17):5123-38. PubMed ID: 19661567
[TBL] [Abstract][Full Text] [Related]
36. Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
Madersbacher S; Pedevilla M; Vingers L; Susani M; Marberger M
Cancer Res; 1995 Aug; 55(15):3346-51. PubMed ID: 7542168
[TBL] [Abstract][Full Text] [Related]
37. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of temperature measurements in ex vivo swine muscle and a tissue-mimicking material during high intensity focused ultrasound exposures.
Maruvada S; Liu Y; Pritchard WF; Herman BA; Harris GR
Phys Med Biol; 2012 Jan; 57(1):1-19. PubMed ID: 22127191
[TBL] [Abstract][Full Text] [Related]
39. Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound.
Moonen CT
Clin Cancer Res; 2007 Jun; 13(12):3482-9. PubMed ID: 17575210
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback.
Chopra R; Tang K; Burtnyk M; Boyes A; Sugar L; Appu S; Klotz L; Bronskill M
Phys Med Biol; 2009 May; 54(9):2615-33. PubMed ID: 19351975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
